- Q1 2024 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2024$33.03 (+5.55%)Earnings
- Arrowhead Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q4 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 29, 2023$29.02 (+1.01%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst and Investor Event on Plozasiran and Zodasiran (Virtual) TranscriptNov 13, 2023
- Arrowhead Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q3 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2023$30.94 (-3.49%)Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Arrowhead Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Arrowhead Pharmaceuticals Inc R&D Day TranscriptJun 01, 2023
- Q2 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023$35.18 (-1.59%)Earnings
- Q1 2023 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2023$33.69 (-9.84%)Earnings
- Arrowhead Pharmaceuticals Inc to Present Topline Data from the Phase 2 SEQUOIA Study TranscriptJan 09, 2023
- Q4 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 28, 2022$29.26 (+0.86%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst and Investor Event TranscriptNov 09, 2022
- Q3 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$44.17Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Arrowhead Pharmaceuticals Inc Pulmonary R&D Day TranscriptMay 26, 2022
- Arrowhead Pharmaceuticals Inc at UBS Global Healthcare Conference TranscriptMay 25, 2022
- Arrowhead Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Arrowhead Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q2 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022$34.23 (-8.96%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 17, 2022
- Q1 2022 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 02, 2022$51.97Earnings
- Q4 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 22, 2021$71.73 (+1.57%)Earnings
- Arrowhead Pharmaceuticals Inc ARO-C3 KOL Webinar TranscriptOct 26, 2021
- Arrowhead Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q3 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$69.44Earnings
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Arrowhead Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- Q2 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2021$66.75 (-6.68%)Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 18, 2021
- Q1 2021 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 04, 2021$82.64 (+1.80%)Earnings
- Q4 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 23, 2020$70.75Earnings
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-ANG3 TranscriptNov 19, 2020
- Arrowhead Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-APOC3 TranscriptNov 18, 2020
- Arrowhead Pharmaceuticals Inc and Takeda Pharmaceutical Co Ltd Collaboration and Licensing Agreement to Develop ARO-AAT Conference Call TranscriptOct 08, 2020
- Q3 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020$47.73Earnings
- Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-ENaC TranscriptJul 28, 2020
- Arrowhead Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q2 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$35.5Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 19, 2020
- Arrowhead Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q1 2020 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 05, 2020$43.95Earnings
- Q4 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptNov 25, 2019$58.05 (+18.76%)Earnings
- Arrowhead Pharmaceuticals Inc Analyst R&D Day TranscriptOct 18, 2019
- Q3 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2019$28.82Earnings
- Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q2 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019$17.33Earnings
- Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMar 14, 2019
- Arrowhead Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q1 2019 Arrowhead Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019$14.3Earnings
Arrowhead Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript
Welcome back, everyone, to the 5th Annual H.C. Wainwright NASH Conference. My name is Patrick Trucchio, and I am a senior biotech analyst at H.C. Wainwright. It is my pleasure to introduce our next presenter, James Hamilton, Senior VP of Discovery and Translational Medicine at Arrowhead Pharmaceuticals, a clinical stage biopharmaceutical company developing medicines to treat intractable disease by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
Questions & Answers
So just to begin, James, if we could start with an overview of the Arrowhead TRiM platform, where it is today and where it could go in the future and why it could conceivably be an ideal platform to develop a potential therapy for NASH?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)